Avanos Medical (AVNS) FCF Margin Growth (3y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 38.00 |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 30.00 |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 943.00 |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 96.00 |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -2,196.00 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -20.00 |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 2,679.00 |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -461.00 |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 417.00 |
| 10 | Avanos Medical | 1.17 Bn | 1.10 Bn | 94.20 Mn | -233.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -233.00 |
| Dec 31, 2025 | 402.00 |
| Sep 30, 2025 | -947.00 |
| Jun 30, 2025 | -1,580.00 |
| Mar 31, 2025 | 1,296.00 |
| Dec 31, 2024 | -13,906.00 |
| Sep 30, 2024 | 174.00 |
| Jun 30, 2024 | 766.00 |
| Mar 31, 2024 | -230.00 |
| Dec 31, 2023 | -300.00 |
| Sep 30, 2023 | 1,573.00 |
| Jun 30, 2023 | -35.00 |
| Mar 31, 2023 | -68.00 |
| Dec 31, 2022 | 3,013.00 |
| Sep 30, 2022 | 2,723.00 |
| Jun 30, 2022 | 4,522.00 |
| Mar 31, 2022 | 2,006.00 |
| Dec 31, 2021 | 19,019.00 |
| Sep 30, 2021 | 5,754.00 |
| Jun 30, 2021 | 7,209.00 |
| Mar 31, 2021 | -1,566.00 |
| Dec 31, 2020 | -4,732.00 |
| Sep 30, 2020 | -727.00 |
| Jun 30, 2020 | -1,246.00 |
| Mar 31, 2020 | -2,449.00 |
| Dec 31, 2019 | 407.00 |
| Sep 30, 2019 | -2,447.00 |
| Jun 30, 2019 | -4,317.00 |
| Mar 31, 2019 | -3,065.00 |
| Dec 31, 2018 | -245.00 |
| Sep 30, 2018 | -4,747.00 |
| Jun 30, 2018 | -6,661.00 |
| Mar 31, 2018 | 763.00 |
| Dec 31, 2017 | 3,615.00 |
| Sep 30, 2017 | 840.00 |
| Jun 30, 2017 | -17.00 |
| Mar 31, 2017 | 1,399.00 |
| Dec 31, 2016 | -3,644.00 |